Middle East and Africa BioSurgery Market Report

Middle East and Africa BioSurgery Market Size

The Middle East and Africa bioSurgery market size was valued at USD 33.27 billion in 2025 and is anticipated to reach USD 35.98 billion in 2026 from USD 67.29 billion by 2034, growing at a CAGR of 8.14% during the forecast period from 2026 to 2034.

Biosurgery products are mainly used in the post-surgical care of patients or the field of orthopedics, or even in the process of hard tissue regeneration in ortho-biologics. Most biosurgery products work on the principle of facilitating homeostasis and tissue healing in surgery.

Biosurgery products are used in various surgeries to minimize intra and post-operative complications. A variety of synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries to prevent excessive blood loss or providing adhesion or wound/tissue sealing, and for the repair of damaged or weakened tissues or bones of a body. These advanced products help by enhancing physicians' work efficiency by controlling surgery-related difficulties in expensive and complicated surgeries.

The major driver of the Middle East and Africa BioSurgery market is the increase in the geriatric population and the changing lifestyles worldwide. The rise in the number of spinal and sports injuries is also driving forward the biosurgery market as consumers also become aware of the latest medical practices.

However, the increasing costs of surgeries, the rising preference of consumers for minimally invasive surgery techniques, along the ethical concerns in some parts of the region are restraining the growth of the market in the Middle-East and Africa.

KEY MARKET PLAYERS

Key market participants leading the Middle East & Africa Biosurgery Market include

• Baxter International
• C.R. Bard
• Johnson & Johnson
• Covidien PLC
• Getinge Group
• B. Braun Melsungen AG
• CryoLife, Inc.
• Stryker Corporation
• Hemostasis LLC
• Sanofi Group

MARKET SEGMENTATION

This research report on the Middle East and Africa BioSurgery Market has been segmented and sub-segmented into the following categories.

By Type

• Sealants
• Hemostatic Agents
• Adhesion Barriers
• Soft Tissue Attachments
• Bone Graft Substitutes
• Staple line Reinforcement Agents

By Application

• Orthopedic
• General
• Neurological
• Cardiovascular
• Reconstructive
• Gynecological
• Urological
• Thoracic Surgeries

By Country

• KSA

• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan, rest of MEA